0001140361-14-012233.txt : 20140311 0001140361-14-012233.hdr.sgml : 20140311 20140311190250 ACCESSION NUMBER: 0001140361-14-012233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140307 FILED AS OF DATE: 20140311 DATE AS OF CHANGE: 20140311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCHENRY GEORGE E JR CENTRAL INDEX KEY: 0000938838 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 14685718 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc1.xml FORM 4 X0306 4 2014-03-07 0 0000722723 HANGER, INC. HGR 0000938838 MCHENRY GEORGE E JR 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 Executive Vice President, CFO Common Stock 2014-03-07 4 S 0 2300 37.309 D 76944 D Common Stock 2014-03-11 4 S 0 1625 36.8046 D 75319 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. These shares were sold at a range of sale prices from $37.19 to $37.48. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were sold at a range of sale prices from $36.64 to $36.92. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares and fully vested shares totaling 8,667 shares of stock from an initial grant of 10,292 shares of restricted stock and performance shares made on March 11, 2013; (ii) unvested restricted shares and fully vested shares totaling 8,180 shares from an initial grant of 9,200 shares of restricted stock and performance shares made on August 14, 2012, (iii) unvested restricted shares and fully vested shares totaling 5,781 shares from an initial grant of 9,200 shares of restricted stock and performance shares made on March 7, 2012, (iv) unvested restricted shares and fully vested shares totaling 11,271 shares from an initial grant of 14,154 shares of restricted stock and performance shares made on March 25, 2011, (v) unvested restricted shares and fully vested shares totaling 17,588 shares from an initial grant of 25,300 shares of restricted stock and performance shares made on March, 30, 2010, [continued in next footnote] (vi) fully vested shares totaling 7,660 shares from an initial grant of 22,680 shares of restricted stock and performance shares made on November 13, 2008, (vii) fully vested shares totaling 9,700 shares from an initial grant of 40,000 shares of restricted stock and performance shares made on August 9, 2007, and (viii) fully vested shares totaling 6,472 shares from an initial grant of 35,000 shares of restricted stock made on June 12, 2006. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for George E. McHenry, Jr. 2014-03-11